Price movement over the last 24 hours
Adaptive Biotechnologies Corp vs United States Oil ETF — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while United States Oil ETF trades at $112.35. The key difference: Adaptive Biotechnologies Corp is trading nearer its 52-week high, United States Oil ETF nearer its low. Which is the better fit depends on your goals.
| ADPT | USO | |
|---|---|---|
Market Cap | $3.33B | — |
Sector | Health | — |
52-Week High | $22.37 | $152.96 |
52-Week Low | $10.24 | $66.17 |
Enterprise Value | $3.19B | — |
Trailing returns across standard periods
Latest headlines on both assets
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →